• New Era in Deafness Treatment : FDA Clears First Gene Therapy to Restore Hearing
    28 April 2026

    New Era in Deafness Treatment : FDA Clears First Gene Therapy to Restore Hearing

    In a landmark medical breakthrough, the U.S. Food and Drug Administration has approved the world’s first gene therapy designed to treat a rare form of inherited hearing loss, marking a major step toward curing, not just managing, deafness.

  • 24 March 2026
    Takeda's Dengue Vaccine Clears India's Expert Panel, Approval Imminent

    India has moved a decisive step closer to having its first tetravalent dengue vaccine on the market after a Subject Expert Committee (SEC) under the Drugs Controller General of India (DCGI) recommended approving Takeda Biopharmaceuticals' Dengue Tetravalent Vaccine (TDV) for import and use in individuals aged 4 to 60 years.

  • 21 January 2026
    India’s Homegrown Antibiotic Moves Closer to Europe as Wockhardt Files EMA Application
    Wockhardt has taken a major step in global healthcare by filing a Marketing Authorisation Application with the European Medicines Agency, EMA for its new antibiotic WCK 5222
  • 20 January 2026
    Mounjaro : A strong performer in the last 9 months

    Mounjaro (tirzepatide) has emerged as one of the most impactful brands in the GLP‑1 category, showing remarkable traction over the last nine months. With growing acceptance among clinicians and increasing awareness among patients, Mounjaro’s performance reflects both strong clinical confidence and rising demand in the metabolic therapy space.

  • 1 January 2026
    Peptides in Cosmetics

    Vinay KumarVinay Kumar Singh. 
    Head-Formulation
    Kumar Organic Products Research Centre Pvt. Ltd.,
    Bengaluru
    Email : formulation_krc@kopresearchcentre.net

  • 26 December 2025
    New Research finds ADHD Stimulant medications work in unexpected way

    Researchers at Washington University School of Medicine in St. Louis suggest that common stimulant medications used to treat attention-deficit/hyperactivity disorder (ADHD), such as Ritalin and Adderall, may work in ways scientists didn’t previously understand. The findings challenge the long-held belief that these drugs primarily improve attention by acting directly on the brain’s attention circuits.

  • 19 December 2025
    Regulatory Harmonization and India’s Global Pharma Credibility

    In global pharmaceuticals, credibility is no longer conferred by capacity alone. It is earned— slowly, visibly, and irreversibly—through regulatory trust. As drug supply chains fragment, re- regionalize, and digitize, the decisive question for India’s pharmaceutical future is no longer how much we manufacture, but how seamlessly our regulatory systems align with the world we serve.

  • 18 December 2025
    Clues to Alzheimer’s disease may be hiding in our ‘junk’ DNA
    When most of us think of DNA, we have a vague idea it’s made up of genes that give us our physical features, our behavioural quirks, and keep our cells and organs running.
  • 17 December 2025
    Kopulan Strips-for Sublingual Administration of Active

    Vinay KumarVinay Kumar Singh. 
    Head-Formulation
    Kumar Organic Products Research Centre Pvt. Ltd.,
    Bengaluru
    Email : formulation_krc@kopresearchcentre.net

  • 5 December 2025
    How influenza viruses enter our cells

    Fever, aching limbs and a runny nose – as winter returns, so too does the flu. The disease is triggered by influenza viruses, which enter our body through droplets and then infect cells.

    Researchers from Switzerland and Japan have now investigated this virus in minute detail. Using a microscopy technique that they developed themselves, the scientists can zoom in on the surface of human cells in a Petri dish. For the first time, this has allowed them to observe live and in high resolution how influenza viruses enter a living cell.

Subscribe to Pharmapedia